3 clinical trials registered, 2 recruiting. Interventions under study include drug therapy, other interventions, and medical devices. Pipeline includes 1 PHASE3, 1 PHASE2. Research is primarily sponsored by academic and government institutions.
299 publications have been identified in PubMed for B-cell childhood acute lymphoblastic leukemia. Kisho has analyzed 224 by research type. Research spans Basic Science / Preclinical (33%), Review / Meta-Analysis (17%), and Clinical Trial Publication (16%).
Hamidi R (2026). [PMID: 41747190](https://pubmed.ncbi.nlm.nih.gov/41747190/). *Blood Adv*. [Review / Meta-Analysis]
Kim HY (2026). [PMID: 41093603](https://pubmed.ncbi.nlm.nih.gov/41093603/). *Ann Lab Med*. [Diagnostic / Biomarker]
Li YQ (2026). [PMID: 42015709](https://pubmed.ncbi.nlm.nih.gov/42015709/). *Zhongguo Dang Dai Er Ke Za Zhi*. [Review / Meta-Analysis]
Cosgun KN (2026). [PMID: 41507538](https://pubmed.ncbi.nlm.nih.gov/41507538/). *Nat Cancer*. [Gene Therapy / Novel Therapeutics]
Syed YY (2026). [PMID: 41697594](https://pubmed.ncbi.nlm.nih.gov/41697594/). *Paediatr Drugs*. [Review / Meta-Analysis]
Xu Y (2026). [PMID: 41851457](https://pubmed.ncbi.nlm.nih.gov/41851457/). *Nature*. [Basic Science / Preclinical]
McCall D (2026). [PMID: 40324358](https://pubmed.ncbi.nlm.nih.gov/40324358/). *Acta Haematol*. [Review / Meta-Analysis]
Gupta SK (2026). [PMID: 40899517](https://pubmed.ncbi.nlm.nih.gov/40899517/). *Int J Lab Hematol*. [Epidemiology / Natural History]
Wang M (2026). [PMID: 41780199](https://pubmed.ncbi.nlm.nih.gov/41780199/). *Leuk Res*. [Review / Meta-Analysis]
Navarro V (2026). [PMID: 41691095](https://pubmed.ncbi.nlm.nih.gov/41691095/). *Bone Marrow Transplant*. [Review / Meta-Analysis]
